Nokia hails ‘unprecedented’ private 5G trial at vaccine plant in Brazil
RCR Wireless
NOVEMBER 12, 2024
Bio-Manguinhos produces active pharmaceutical ingredients (APIs; not those ones) for vaccines for mumps and measles, among other things. The new solution “could prevent […] The post Nokia hails ‘unprecedented’ private 5G trial at vaccine plant in Brazil appeared first on RCR Wireless News.
Let's personalize your content